Life Sciences
FIH Partners advises Coloplast on the acquisition of Kerecis, an innovative fast-growing company in the biologics wound care segment
Learn moreSince the dawn of biotech IPOs in Denmark in the mid-1990s, the partners of FIH Partners have been actively advising pharma, medtech, biotech and medical supplies companies.
Over the years, we have developed a detailed understanding of the commercial, scientific and regulatory drivers and risks associated with operating in the sector.
Examples of our experience in healthcare: